Mechanistic Population Pharmacokinetic Model of Oseltamivir and Oseltamivir Carboxylate Accounting for Physiological Changes to Predict Exposures in Neonates and Infants-Reference-Cited by-同舟云学术

Mechanistic Population Pharmacokinetic Model of Oseltamivir and Oseltamivir Carboxylate Accounting for Physiological Changes to Predict Exposures in Neonates and Infants

Published:2020-02-26 Issue:1 Volume:108 Page:126-135
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Gibiansky Leonid¹,Ravva Patanjali²³,Parrott Neil J.⁴,Bhardwaj Rajinder⁵,Zwanziger Elke⁴,Grimsey Paul⁶,Clinch Barry⁷,Sturm Stefan⁴

Affiliation:

1. QuantPharm LLC North Potomac Maryland USA

2. Roche Innovation Center New York Roche Pharmaceutical Research and Early Development New York New York USA

3. Pfizer IncGlobal Clinical Pharmacology New York New York USA

4. Roche Innovation Center Basel Roche Pharmaceutical Research and Early Development Basel Switzerland

5. Integrated Drug Development Certara Strategic Consulting Parsippany New Jersey USA

6. Roche Innovation Center Welwyn Roche Pharmaceutical Research and Early Development Welwyn Garden City UK

7. Roche Products Limited Product Development Welwyn Garden City UK

Funder

Roche

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1791

Reference32 articles.

1. Food and Drug Administration.Oseltamivir package insert. Accessed August 15 2019.

2. Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802

3. Pharmacokinetics and Dosage Recommendations for an Oseltamivir Oral Suspension for the Treatment of Influenza in Children

4. Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza

5. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influenza Viruses;Physician Assistant Clinics;2023-07

2. Dosing regimen optimisation for oseltamivir in immunocompromised paediatric patients with influenza: Extrapolation of efficacy;British Journal of Clinical Pharmacology;2021-10-15

3. Population pharmacokinetics of unbound valproic acid in pediatric epilepsy patients in China: a protein binding model;European Journal of Clinical Pharmacology;2021-01-10

4. Pharmacotherapy for acute respiratory infections caused by influenza viruses: current possibilities;Terapevticheskii arkhiv;2021-01-10